ReP USP - Resultado da busca

Filtros : " IFSC777" "Materials Advances" Removido: "Avansi Junior, Waldir" Limpar

Filtros

USP affiliated authors
- comparetti, edson josé (2)
- zucolotto, valtencir (2)
- estevão, bianca martins (1)
- lins, paula maria pincela (1)
- quitiba, joão victor brandão (1)

Artigo de periodico
Anti-GPC1-modified mesoporous silica nanoparticles as nanocarriers for combination therapy and targeting of PANC-1 cells (2021)
Estevão, Bianca Martins ; Comparetti, Edson José ; Rissi, Nathália Cristina; Zucolotto, Valtencir
Source: Materials Advances. Unidade: IFSC
Subjects: NEOPLASIAS, BIOMEDICINA, POLÍMEROS (MATERIAIS), NANOTECNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ESTEVÃO, Bianca Martins et al. Anti-GPC1-modified mesoporous silica nanoparticles as nanocarriers for combination therapy and targeting of PANC-1 cells. Materials Advances, v. 2, n. 15, p. 5224-5235, 2021Tradução . . Disponível em: https://doi.org/10.1039/d1ma00225b. Acesso em: 01 jun. 2024.
APA
Estevão, B. M., Comparetti, E. J., Rissi, N. C., & Zucolotto, V. (2021). Anti-GPC1-modified mesoporous silica nanoparticles as nanocarriers for combination therapy and targeting of PANC-1 cells. Materials Advances, 2( 15), 5224-5235. doi:10.1039/d1ma00225b
NLM
Estevão BM, Comparetti EJ, Rissi NC, Zucolotto V. Anti-GPC1-modified mesoporous silica nanoparticles as nanocarriers for combination therapy and targeting of PANC-1 cells [Internet]. Materials Advances. 2021 ; 2( 15): 5224-5235.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1039/d1ma00225b
Vancouver
Estevão BM, Comparetti EJ, Rissi NC, Zucolotto V. Anti-GPC1-modified mesoporous silica nanoparticles as nanocarriers for combination therapy and targeting of PANC-1 cells [Internet]. Materials Advances. 2021 ; 2( 15): 5224-5235.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1039/d1ma00225b
Artigo de periodico
Cancer cell membrane-derived nanoparticles improve the activity of gemcitabine and paclitaxel on pancreatic cancer cells and coordinate immunoregulatory properties on professional antigen-presenting cells (2020)
Comparetti, Edson José ; Lins, Paula Maria Pincela ; Quitiba, João Victor Brandão; Zucolotto, Valtencir
Source: Materials Advances. Unidade: IFSC
Subjects: NANOTECNOLOGIA, BIOMEDICINA, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COMPARETTI, Edson José et al. Cancer cell membrane-derived nanoparticles improve the activity of gemcitabine and paclitaxel on pancreatic cancer cells and coordinate immunoregulatory properties on professional antigen-presenting cells. Materials Advances, v. 1, n. 6, p. 1775-1787, 2020Tradução . . Disponível em: https://doi.org/10.1039/d0ma00367k. Acesso em: 01 jun. 2024.
APA
Comparetti, E. J., Lins, P. M. P., Quitiba, J. V. B., & Zucolotto, V. (2020). Cancer cell membrane-derived nanoparticles improve the activity of gemcitabine and paclitaxel on pancreatic cancer cells and coordinate immunoregulatory properties on professional antigen-presenting cells. Materials Advances, 1( 6), 1775-1787. doi:10.1039/d0ma00367k
NLM
Comparetti EJ, Lins PMP, Quitiba JVB, Zucolotto V. Cancer cell membrane-derived nanoparticles improve the activity of gemcitabine and paclitaxel on pancreatic cancer cells and coordinate immunoregulatory properties on professional antigen-presenting cells [Internet]. Materials Advances. 2020 ; 1( 6): 1775-1787.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1039/d0ma00367k
Vancouver
Comparetti EJ, Lins PMP, Quitiba JVB, Zucolotto V. Cancer cell membrane-derived nanoparticles improve the activity of gemcitabine and paclitaxel on pancreatic cancer cells and coordinate immunoregulatory properties on professional antigen-presenting cells [Internet]. Materials Advances. 2020 ; 1( 6): 1775-1787.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1039/d0ma00367k

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024